Medical treatment of endocarditis

[1]  J. E. Bennett,et al.  Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases , 2014 .

[2]  E. Abrutyn,et al.  Chapter 4. Infective Endocarditis , 2007 .

[3]  Carmen Torres,et al.  Brief Communication: Treatment of Enterococcus faecalis Endocarditis with Ampicillin plus Ceftriaxone , 2007, Annals of Internal Medicine.

[4]  杜昕,et al.  Infective endocarditis , 2007 .

[5]  Vance G Fowler,et al.  Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. , 2006, The New England journal of medicine.

[6]  D. Paterson,et al.  Epidemiological profile of linezolid-resistant coagulase-negative staphylococci. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  B. Hoen,et al.  Prosthetic valve endocarditis due to coagulase-negative staphylococci: findings from the International Collaboration on Endocarditis Merged Database , 2006, European Journal of Clinical Microbiology and Infectious Diseases.

[8]  H. Chambers,et al.  Efficacy of Telavancin in a Rabbit Model of Aortic Valve Endocarditis Due to Methicillin-Resistant Staphylococcus aureus or Vancomycin-Intermediate Staphylococcus aureus , 2005, Antimicrobial Agents and Chemotherapy.

[9]  Bruno Hoen,et al.  Staphylococcus aureus endocarditis: a consequence of medical progress. , 2005, Journal of the American Medical Association (JAMA).

[10]  Walter R Wilson,et al.  Temporal trends in infective endocarditis: a population-based study in Olmsted County, Minnesota. , 2005, JAMA.

[11]  C. Tribouilloy,et al.  Superiority of surgical versus medical treatment in patients with Staphylococcus aureus infective endocarditis. , 2005, International journal of cardiology.

[12]  S. Armstrong,et al.  Aortic and mitral valve replacement with reconstruction of the intervalvular fibrous body: an analysis of clinical outcomes. , 2005, The Journal of thoracic and cardiovascular surgery.

[13]  J. Gatell,et al.  Staphylococcus lugdunensis infective endocarditis: description of 10 cases and analysis of native valve, prosthetic valve, and pacemaker lead endocarditis clinical profiles , 2005, Heart.

[14]  Gilbert Habib,et al.  Native valve endocarditis due to coagulase-negative staphylococci: report of 99 episodes from the International Collaboration on Endocarditis Merged Database. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  A. Yinnon,et al.  Latent infective endocarditis: epidemiology and clinical characteristics of patients with unsuspected endocarditis detected after elective valve replacement. , 2004, The Annals of thoracic surgery.

[16]  Jerome J. Schentag,et al.  Accessory gene regulator group II polymorphism in methicillin-resistant Staphylococcus aureus is predictive of failure of vancomycin therapy. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[17]  G. Eliopoulos,et al.  Relationship of MIC and Bactericidal Activity to Efficacy of Vancomycin for Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia , 2004, Journal of Clinical Microbiology.

[18]  P. Ward,et al.  Treatment outcomes for serious infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[19]  Ronald N. Jones,et al.  Worldwide assessment of dalbavancin activity and spectrum against over 6,000 clinical isolates. , 2004, Diagnostic microbiology and infectious disease.

[20]  D. Turner,et al.  Vancomycin-resistant Enterococcus faecium endocarditis in a premature infant successfully treated with linezolid. , 2003, The Pediatric infectious disease journal.

[21]  Kavindra V. Singh,et al.  Relapse of type A beta-lactamase-producing Staphylococcus aureus native valve endocarditis during cefazolin therapy: revisiting the issue. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  Vance G Fowler,et al.  Surgical treatment of pacemaker and defibrillator lead endocarditis: the impact of electrode lead extraction on outcome. , 2003, Chest.

[23]  M. Crespo,et al.  Efficacy of ampicillin combined with ceftriaxone and gentamicin in the treatment of experimental endocarditis due to Enterococcus faecalis with no high-level resistance to aminoglycosides. , 2003, The Journal of antimicrobial chemotherapy.

[24]  G. Kaye,et al.  Successful use of oral linezolid as a single active agent in endocarditis unresponsive to conventional antibiotic therapy. , 2003, The Journal of infection.

[25]  G. Talbot,et al.  Endocarditis due to vancomycin-resistant Enterococcus faecium in an immunocompromised patient: cure by administering combination therapy with quinupristin/dalfopristin and high-dose ampicillin. , 2003, Southern medical journal.

[26]  V. Yu,et al.  Staphylococcus lugdunensis Endocarditis—The Hidden Peril of Coagulase-Negative Staphylococcus in Blood Cultures , 2003, European Journal of Clinical Microbiology and Infectious Diseases.

[27]  G. Eliopoulos,et al.  Efficacy of Daptomycin in Experimental Endocarditis Due to Methicillin-Resistant Staphylococcusaureus , 2003, Antimicrobial Agents and Chemotherapy.

[28]  G. Eliopoulos.  Quinupristin-dalfopristin and linezolid: evidence and opinion. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[29]  Daniel J Sexton,et al.  Health CareAssociated Bloodstream Infections in Adults: A Reason To Change the Accepted Definition of Community-Acquired Infections , 2002, Annals of Internal Medicine.

[30]  C. Tuazon,et al.  Endocarditis caused by methicillin-resistant Staphylococcus aureus: treatment failure with linezolid. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[31]  Bruno Hoen,et al.  Changing profile of infective endocarditis: results of a 1-year survey in France. , 2002, JAMA.

[32]  A. Karchmer,et al.  Infections of intracardiac devices. , 2002, Infectious disease clinics of North America.

[33]  Vance G Fowler,et al.  Changing patient characteristics and the effect on mortality in endocarditis. , 2002, Archives of internal medicine.

[34]  E. Mylonakis,et al.  Infective endocarditis in adults. , 2001, New England Journal of Medicine.

[35]  Mary Jane Ferraro,et al.  Linezolid resistance in a clinical isolate of Staphylococcus aureus , 2001, The Lancet.

[36]  P. Martín-Dávila,et al.  Short-course therapy for right-side endocarditis due to Staphylococcus aureus in drug abusers: cloxacillin versus glycopeptides in combination with gentamicin. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[37]  H. Babcock,et al.  Successful treatment of vancomycin-resistant Enterococcus endocarditis with oral linezolid. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[38]  Robin Patel,et al.  Linezolid Therapy of Vancomycin-ResistantEnterococcus faecium Experimental Endocarditis , 2001, Antimicrobial Agents and Chemotherapy.

[39]  G. Procop,et al.  Antimicrobial susceptibility of Abiotrophia adiacens and Abiotrophia defectiva. , 2000, Diagnostic microbiology and infectious disease.

[40]  J. Perfect,et al.  Treatment of methicillin-resistant Staphylococcus aureus infections with quinupristin–dalfopristin in patients intolerant of or failing prior therapy , 2000 .

[41]  R. Proctor.  Editorial response: coagulase-negative staphylococcal infections: A diagnostic and therapeutic challenge. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[42]  M. Struelens,et al.  Polyclonal Staphylococcal endocarditis caused by genetic variability. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[43]  S. Langley,et al.  Surgery for active culture-positive endocarditis: determinants of early and late outcome. , 2000, The Annals of thoracic surgery.

[44]  D. McGiffin,et al.  Cardiac transplantation for prosthetic valve endocarditis in a previously transplanted heart. , 1999, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[45]  R. Salamon,et al.  Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients. , 1999, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[46]  F. Baquero,et al.  Efficacy of Ampicillin plus Ceftriaxone in Treatment of Experimental Endocarditis Due to Enterococcus faecalis Strains Highly Resistant to Aminoglycosides , 1999, Antimicrobial Agents and Chemotherapy.

[47]  D. Durack,et al.  Ceftriaxone once daily for four weeks compared with ceftriaxone plus gentamicin once daily for two weeks for treatment of endocarditis due to penicillin-susceptible streptococci. Endocarditis Treatment Consortium Group. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[48]  Roy Feldman,et al.  Dental and Cardiac Risk Factors for Infective Endocarditis: A Population-Based, Case-Control Study , 1998, Annals of Internal Medicine.

[49]  P L Hibberd,et al.  Staphylococcus aureus prosthetic valve endocarditis: optimal management and risk factors for death. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[50]  B. Isalska,et al.  Aspects of prosthetic valve endocarditis. , 1997, The Journal of infection.

[51]  I. Ocaña,et al.  Effectiveness of Cloxacillin with and without Gentamicin in Short-Term Therapy for Right-Sided Staphylococcus aureus Endocarditis , 1996, Annals of Internal Medicine.

[52]  C Flexner,et al.  Oral antibiotic treatment of right-sided staphylococcal endocarditis in injection drug users: prospective randomized comparison with parenteral therapy. , 1996, The American journal of medicine.

[53]  C. Stratton,et al.  Effective treatment of multidrug-resistant enterococcal experimental endocarditis with combinations of cell wall-active agents. , 1996, The Journal of infectious diseases.

[54]  W. Baumgartner,et al.  Valve replacement in patients with endocarditis and acute neurologic deficit. , 1996, The Annals of thoracic surgery.

[55]  A. Bisno,et al.  Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci, and HACEK microorganisms. American Heart Association. , 1995, JAMA.

[56]  P. Francioli,et al.  Treatment of streptococcal endocarditis with a single daily dose of ceftriaxone and netilmicin for 14 days: a prospective multicenter study. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[57]  E Abrutyn,et al.  Incidence of infective endocarditis in the Delaware Valley, 1988-1990. , 1995, The American journal of cardiology.

[58]  L. Olaison,et al.  Epidemiologic Aspects of Infective Endocarditis in an Urban Population: A 5‐Year Prospective Study , 1995, Medicine.

[59]  R. Écochard,et al.  Characteristics of infective endocarditis in France in 1991. A 1-year survey. , 1995, European heart journal.

[60]  G. Trenholme,et al.  Bactericidal activities of antibiotics against vancomycin-resistant Enterococcus faecium blood isolates and synergistic activities of combinations , 1994, Antimicrobial Agents and Chemotherapy.

[61]  F. Vandenesch,et al.  Endocarditis due to Staphylococcus lugdunensis: report of 11 cases and review. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[62]  V L Yu,et al.  Prosthetic Valve Endocarditis Resulting from Nosocomial Bacteremia: A Prospective, Multicenter Study , 1993, Annals of Internal Medicine.

[63]  W. Wilson,et al.  Relative efficacies of broad-spectrum cephalosporins for treatment of methicillin-susceptible Staphylococcus aureus experimental infective endocarditis , 1993, Antimicrobial Agents and Chemotherapy.

[64]  M. Herrmann,et al.  Successful therapy of experimental chronic foreign-body infection due to methicillin-resistant Staphylococcus aureus by antimicrobial combinations , 1991, Antimicrobial Agents and Chemotherapy.

[65]  B. R. Reddy,et al.  Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis. , 1991, Annals of internal medicine.

[66]  B. Fantin,et al.  Importance of the aminoglycoside dosing regimen in the penicillin-netilmicin combination for treatment of Enterococcus faecalis-induced experimental endocarditis , 1990, Antimicrobial Agents and Chemotherapy.

[67]  W. Wilson,et al.  Ciprofloxacin therapy of experimental endocarditis caused by methicillin-resistant Staphylococcus epidermidis , 1990, Antimicrobial Agents and Chemotherapy.

[68]  M. Sande,et al.  TREATMENT OF RIGHT-SIDED STAPHYLOCOCCUS AUREUS ENDOCARDITIS IN INTRAVENOUS DRUG USERS WITH CIPROFLOXACIN AND RIFAMPICIN , 1989, The Lancet.

[69]  G. Archer,et al.  Staphylococcus epidermidis causing prosthetic valve endocarditis: microbiologic and clinical observations as guides to therapy. , 1983, Annals of internal medicine.

[70]  M. Sande,et al.  Combination antimicrobial therapy for Staphylococcus aureus endocarditis in patients addicted to parenteral drugs and in nonaddicts: A prospective study. , 1982, Annals of internal medicine.

[71]  A. Karchmer,et al.  Endocarditis due to coagulase-negative staphylococci. Microbiologic, epidemiologic, and clinical considerations. , 1993, Infectious disease clinics of North America.

[72]  John E. Bennett,et al.  Principles and practice of infectious diseases. Vols 1 and 2. , 1979 .

[73]  Traut Ef.  Endocarditis in the elderly. , 1948 .